In the media

Trials in Immune-Oncology

The expansion of immunotherapies is a key trend to watch in cancer research

28 August, Sophie Laurenson, PhD

Immunotherapy describes a set of therapies that leverage the capacity of the immune system to combat disease. Recent clinical successes of immunotherapies have made this an active field of research. It is considered one of the […]

2019-09-06T00:50:29+00:00September 6th, 2019|

CAR-T Cell Cancer Therapy to Save Lives (Media Release)

The Victorian and Commonwealth Governments work together to make CAR-T Cell Therapy available to patients

  • CAR-T Cell Therapy is one of the most expensive treatments ever to be brought to Australia
  • More than 95 Victorians are diagnosed with cancer every day

The Victorian and Commonwealth Governments have worked together to bring the revolutionary, life-saving new […]

2019-08-05T05:32:50+00:00August 5th, 2019|

Australian Actor Tom Long cancer-free after medical trial

The Age, 28 July 2019

By Melissa Cunningham

Former SeaChange actor Tom Long was on the brink of death when he boarded a flight to the United States in April to take part in a medical trial for terminal blood cancer.

He arrived in Seattle with sunken cheeks and a body ravaged by chemotherapy. Weighing a little more […]

2019-07-29T04:19:34+00:00July 29th, 2019|

Patent office reopens major CRISPR battle between Broad Institute and Univ. of California

STAT Biotech – By Sharon Begley @sxbegle

JUNE 25, 2019

The U.S. patent office has declared an interference between a dozen key patents awarded to the Broad Institute on the genome-editing technology CRISPR and 10 CRISPR patent applications submitted by the University of California and its partners, according to documents posted by the U.S. Patent and […]

2019-07-03T01:17:02+00:00July 3rd, 2019|

Science and Technology priorities – Election 2019


8 May 2019 Parties use science to set themselves apart ….

The major parties have laid out their science and technology platform for Australian voters, with clear differences in their approach and vision for empowering the solutions sector.

Responding to a survey from peak body Science & Technology Australia (STA), the Coalition, the Labor Party and the Greens have all […]

2019-05-08T04:07:34+00:00May 8th, 2019|

It’s time for a worldwide moratorium on editing human embryos

by Alan Trounson

Hear Alan Trounson discuss the issue Saturday 6 April at 12 noon on ABC Radio National’s The Science Show.

A few weeks ago, 18 scientists from seven countries took me back forty years to a time when I was involved with the first IVF birth in Australia. Why? The scientists, writing in the journal […]

2019-04-04T02:18:14+00:00April 2nd, 2019|

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells

UC San Diego Health Treats 1st Cancer Patient with Stem-Cell Derived Natural Killer Cells
Fate Therapeutics, in collaboration with UC San Diego researcher, developed first off-the-shelf immunotherapy from human induced pluripotent stem cells that is now in clinical trials.

April 01, 2019  |  Yadira Galindo

After 10 years in remission, Derek Ruff’s cancer returned, this […]

2019-04-02T02:22:48+00:00April 2nd, 2019|

Tom’s Long Fight

Tom Long’s battle with Multiple Myeloma

Lisa Wilkinson interviewed Aussie Actor and multiple myeloma patient Tom Long on The Sunday Project to help raise awareness for blood cancer and the need for more research in Australia.  The story is heartbreaking, Tom is hanging on to hope.  Hope that a CAR-T cell treatment that he has to […]

2019-03-25T23:18:28+00:00March 25th, 2019|

Australia is handicapped in the delivery of cell therapies, says Alan Trounson

THE promise is remarkable: a new class of affordable, effective cancer treatments beyond surgery, chemotherapy, biologicals and radiation. Imagine cancer specialists being able to select from a range of treatments to supercharge a patient’s immune system, helping it eliminate cancer.

This is not a distant vision. It is happening right here, right now. A research team, […]

2019-03-21T01:00:32+00:00March 21st, 2019|